| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 471 |
| 1 | PALBOCICLIB | 441 |
| 2 | PREDNISONE | 432 |
| 3 | RUXOLITINIB | 421 |
| 4 | LENALIDOMIDE | 387 |
| 5 | RITUXIMAB | 350 |
| 6 | PEGFILGRASTIM | 307 |
| 7 | VENETOCLAX | 272 |
| 8 | ASPIRIN | 268 |
| 9 | ERGOCALCIFEROL | 268 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 307 | 0.0256 |
| 1 | ERGOCALCIFEROL | 268 | 0.0090 |
| 2 | ACALABRUTINIB | 87 | 0.0068 |
| 3 | IBRUTINIB | 471 | 0.0058 |
| 4 | RUXOLITINIB | 421 | 0.0057 |
| 5 | PALBOCICLIB | 441 | 0.0046 |
| 6 | VENETOCLAX | 272 | 0.0043 |
| 7 | DASATINIB | 36 | 0.0039 |
| 8 | ALEMTUZUMAB | 74 | 0.0038 |
| 9 | RIBOCICLIB | 120 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 1539 |
| 1 | Corticosteroid [EPC] | 787 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 725 |
| 3 | Thalidomide Analog [EPC] | 506 |
| 4 | Janus Kinase Inhibitor [EPC] | 468 |
| 5 | Leukocyte Growth Factor [EPC] | 431 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 426 |
| 7 | Opioid Agonist [EPC] | 316 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 277 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 275 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Provitamin D2 Compound [EPC] | 268 | 0.0090 |
| 2 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 11 | 0.0051 |
| 3 | BCL-2 Inhibitor [EPC] | 272 | 0.0043 |
| 4 | CD3-directed Antibody [EPC] | 3 | 0.0042 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 74 | 0.0038 |
| 6 | Interferon alfa-2b [EPC] | 7 | 0.0038 |
| 7 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 8 | 0.0032 |
| 8 | Leukocyte Growth Factor [EPC] | 431 | 0.0030 |
| 9 | Estrogen Receptor Antagonist [EPC] | 120 | 0.0030 |